Sanofi (SNY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sanofi

    NASDAQ: SNY · Real-Time Price · USD
    47.16
    -0.29 (-0.61%)
    At close: Sep 10, 2025, 3:59 PM
    46.75
    -0.87%
    After-hours: Sep 10, 2025, 05:13 PM EDT

    Sanofi Cash Flow Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 5.5B 5.4B 8.37B 6.22B
    Depreciation & Amortization
    		 3.59B 3.78B 3.42B 3.35B
    Stock-Based Compensation
    		 n/a n/a 245M 244M
    Other Working Capital
    		 -899M 1.6B 545M 1.13B
    Other Non-Cash Items
    		 1.42B 1.55B -225M 3M
    Deferred Income Tax
    		 -802M -1.23B -578M -356M
    Change in Working Capital
    		 -615M 764M -707M 1.41B
    Operating Cash Flow
    		 9.08B 10.26B 10.53B 10.52B
    Capital Expenditures
    		 -3.19B -3.02B -2.2B -2.04B
    Cash Acquisitions
    		 -2.52B 1.01B -858M -5.59B
    Purchase of Investments
    		 n/a -134M -488M -311M
    Sales Maturities Of Investments
    		 n/a 42M n/a 718M
    Other Investing Acitivies
    		 1.35B -3.87B 1.47B -68M
    Investing Cash Flow
    		 -4.41B -6.2B -2.08B -7.3B
    Debt Repayment
    		 -894M -3.14B -1.46B -2.65B
    Common Stock Repurchased
    		 -302M -593M -497M -382M
    Dividend Paid
    		 -4.7B -4.45B -4.17B -4.01B
    Other Financial Acitivies
    		 -50M -63M 304M -197M
    Financial Cash Flow
    		 -5.76B -8.05B -5.82B -7.06B
    Net Cash Flow
    		 -1.27B -4.03B 2.64B -3.82B
    Free Cash Flow
    		 5.89B 7.35B 8.32B 8.48B

    Add to Watchlist